Jafron Biomedical Co Ltd
SZSE:300529
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
CN |
|
H
|
Hong Leong Financial Group Bhd
KLSE:HLFG
|
MY |
|
A
|
Astra Exploration Inc
XTSX:ASTR
|
CA |
|
Houpu Clean Energy Group Co Ltd
SZSE:300471
|
CN |
|
IGEA Pharma NV
SIX:IGPH
|
NL |
Wall Street
Price Targets
Price Targets Summary
Jafron Biomedical Co Ltd
According to Wall Street analysts, the average 1-year price target for Jafron Biomedical Co Ltd is 25.59 CNY with a low forecast of 25.34 CNY and a high forecast of 26.34 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jafron Biomedical Co Ltd's stock price target?
Price Target
25.59
CNY
According to Wall Street analysts, the average 1-year price target for Jafron Biomedical Co Ltd is 25.59 CNY with a low forecast of 25.34 CNY and a high forecast of 26.34 CNY.
What is Jafron Biomedical Co Ltd's Revenue forecast?
Projected CAGR
-1%
For the last 10 years the compound annual growth rate for Jafron Biomedical Co Ltd's revenue is 22%. The projected CAGR for the next 3 years is -1%.
What is Jafron Biomedical Co Ltd's Operating Income forecast?
Projected CAGR
4%
For the last 10 years the compound annual growth rate for Jafron Biomedical Co Ltd's operating income is 20%. The projected CAGR for the next 3 years is 4%.
What is Jafron Biomedical Co Ltd's Net Income forecast?
Projected CAGR
-1%
For the last 10 years the compound annual growth rate for Jafron Biomedical Co Ltd's net income is 18%. The projected CAGR for the next 3 years is -1%.
